Stock Alert for Encorium Group Inc. Issued by MicroStockProfit
April 16 2010 - 5:50AM
MicroStockProfit.com announces an investment report featuring
Encorium Group Inc. (Nasdaq:ENCO). The report includes financial,
comparative and investment analyses, and industry information you
need to know to make an educated investment decision.
The full report is available at:
www.microstockprofit.com/ads/ENCO
Encorium Group Inc. (ENCO) is a clinical research organization
(CRO), which is engaged in the design and management of clinical
trials for the pharmaceutical, biotechnology and medical device
industries. The Company's clients consist of companies in the
pharmaceutical, biotechnology and medical device industries. The
Company offers a range of clinical research and development
services supporting phase I through phase IV clinical trials, such
as strategic trial planning, project management, monitoring, data
management and biostatistics, pharmacovigilance, medical writing,
quality assurance, outsourcing of clinical staff and medical device
certification in the European Union. The Company's services include
study protocol design, clinical trials management, global data
management services, biostatistics, medical and regulatory affairs,
quality assurance and compliance, and medical report
writing.
In the report, the analyst notes:
"ENCO recently announced that it will file a Form 12b-25 with
the Securities and Exchange Commission, which will provide the
Company with a 15-calendar day extension for filing its Annual
Report on Form 10-K for the fiscal year ended December 31, 2009.
The Company's independent registered accounting firm has not
completed its audit of the Company's financial statements and has
not provided its report and consent for the Company's Annual
Report. The Company will file its Form 10-K as soon as its
independent registered accounting firm provides its report on those
financial statements and its consent."
To read the entire report visit:
www.microstockprofit.com/ads/ENCO
MicroStockProfit.com is a small-cap research and investment
commentary provider. MicroStockProfit.com strives to provide a
balanced view of many promising small-cap companies that would
otherwise fall under the radar of the typical Wall Street investor.
We provide investors with an excellent first step in their research
and due diligence by providing daily trading ideas, and
consolidating the public information available on them. For more
information on MicroStockProfit please visit:
http://www.microstockprofit.com.
MicroStockProfit.com Disclosure
MicroStockProfit.com is not a registered investment advisor and
nothing contained in any materials should be construed as a
recommendation to buy or sell any securities. MicroStockProfit.com
is a Web site wholly owned by BlueWave Advisors, LLC. Neither
MicroStockProfit.com nor its affiliates have a beneficial interest
in the mentioned company; nor have they received compensation of
any kind for any of the companies listed in this communication.
Please read our report and visit our Web site,
MicroStockProfit.com, for complete risks and disclosures.
CONTACT: MicroStockProfit.com
Brian Johnson
1-888-307-2850
info@microstockprofit.com